株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の経肺ドラッグデリバリーデバイス市場:産業分析、規模、シェア、成長率、動向、予測

Pulmonary Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

発行 Transparency Market Research 商品コード 296305
出版日 ページ情報 英文 238 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.40円で換算しております。
Back to Top
世界の経肺ドラッグデリバリーデバイス市場:産業分析、規模、シェア、成長率、動向、予測 Pulmonary Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
出版日: 2017年02月09日 ページ情報: 英文 238 Pages
概要

当レポートでは、世界の経肺ドラッグデリバリーデバイス市場について調査分析し、産業分析、市場規模と予測、セグメント別の市場分析、地域別の市場分析、競合情勢など、体系的な情報を提供しています。

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

  • 製品タイプの概要
  • 主な産業動向
  • 市場の機会マップ

第5章 市場力学

  • 促進要因・抑制要因スナップショット分析
  • 促進要因
  • 抑制要因
  • 機会分析
  • 機会
  • 動向
  • ファイブフォース分析
  • バリューチェーンスナップショット

第6章 経肺ドラッグデリバリーデバイス市場の分析:製品タイプ別

  • 主な調査結果
  • イントロダクション
  • 市場金額シェア分析
  • 市場予測
  • 市場の魅力分析
  • 主な動向

第7章 経肺ドラッグデリバリーデバイス市場の分析:用途別

  • 主な調査結果
  • イントロダクション
  • 市場金額シェア分析
  • 市場予測
  • 市場の魅力分析
  • 主な動向

第8章 経肺ドラッグデリバリーデバイス市場の分析:流通経路別

  • 主な調査結果
  • イントロダクション
  • 市場金額シェア分析
  • 市場予測
  • 市場の魅力

第9章 経肺ドラッグデリバリーデバイス市場の分析:地域別

  • 世界のシナリオ
  • 市場金額シェア分析
  • 市場予測
  • 市場の魅力分析

第10章 北米の経肺ドラッグデリバリーデバイス市場の分析

第11章 欧州の経肺ドラッグデリバリーデバイス市場の分析

第12章 アジア太平洋地域の経肺ドラッグデリバリーデバイス市場の分析

第13章 ラテンアメリカの経肺ドラッグデリバリーデバイス市場の分析

第14章 中東・アフリカの経肺ドラッグデリバリーデバイス市場の分析

第15章 競合情勢

  • 市場シェア分析:企業別
  • 競合ダッシュボード
  • パイプラインスナップショット

第16章 企業プロファイル

  • Boehringer Ingelheim GmbH
  • Novartis AG
  • GlaxoSmithKline plc
  • AstraZeneca plc
  • Teva Pharmaceutical Industries Ltd.
  • Merck & Co., Inc.
  • MannKind Corporation
  • F. Hoffmann-La Roche Ltd.
  • Bristol-Myers Squibb Company
  • Mylan N.V.
  • オムロン
  • 3M Healthcare
  • Sunovion Pharmaceuticals, Inc.
  • Koninklijke Philips N.V.
  • Gerresheimer AG
  • Bespak
  • AptarGroup, Inc.
  • SHL Group
  • Nypro Healthcare Inc. (Jabil Circuit Inc.)
  • Hovione
  • Chiesi Farmaceutici S.p.A.

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Title: Pulmonary Drug Delivery Devices Market (Product Type - Dry Powder Inhalers, Metered Dose Inhalers and Nebulizers; Application - Asthma, COPD, and Cystic Fibrosis; Distribution Channel - Retail Pharmacies, Hospital Pharmacies, and E-commerce) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.

Global Pulmonary Drug Delivery Devices Market: Overview

This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market.

This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered within the scope of the study. This section also provides the overall information and data analysis of the global pulmonary drug delivery devices market with respect to the leading market segments based on major products, key applications, distribution channels, and geographies.

Global Pulmonary Drug Delivery Devices Market: Segmentation

The global pulmonary drug delivery devices market has been studied based on major product type, application segments, major distribution channels, and regional as well as national markets. Based on product type, the global market has been categorized into three major segments: Dry Powder Inhalers, Metered Dose Inhalers and Nebulizers. Based on application, the global market has been categorized into four segments: Asthma, COPD, cystic fibrosis, and others. Based on distribution channels, the global market has been categorized into three key segments: retail pharmacies, hospital pharmacies, and e-commerce.

The market for these segments has been extensively analyzed based on their utility, effectiveness, sales, and geographic presence. Market revenue in terms of US$ Mn for the period from 2014 to 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all segments, considering 2015 as the base year.

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the global pulmonary drug delivery devices market and could influence the market in the near future. Market attractiveness analysis has been provided in all the sections of the report in order to explain the intensity of competition in the market across different products / applications / distribution channels / geographies.

Global Pulmonary Drug Delivery Devices Market: Regional Overview

Geographically, the pulmonary drug delivery devices market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa (MEA). Each regional market for pulmonary drug delivery devices market has been further categorized into major product, application, and end-user segments considered within the scope of the study.

Key country (U.S., Japan, Germany, France, U.K., Australia, Canada, China, Brazil, Mexico, India, etc.) market revenues have also been provided in different regional sections within the report. Market revenue in terms of US$ Mn for the period from 2014 to 2024 along with CAGR % from 2016 to 2024 are provided for all the regions and nations considering 2015 as the base year.

Global Pulmonary Drug Delivery Devices Market: Competitive Outlook

The competitive scenario among different market players is evaluated through market share analysis in the competition landscape section of the pulmonary drug delivery devices market report. The section also includes competition matrix that analyzes the competition among some of the top global players operating in the market. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global pulmonary drug delivery devices market.

The report also profiles key players operating in the pulmonary drug delivery devices market based on various attributes such as company details, SWOT analysis, strategic overview, financials, and business overview. Major players profiled in this report include AstraZeneca plc, Novartis AG, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Merck & Co., Inc, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, 3M Healthcare, Omron Corporation, and others.

The global pulmonary drug delivery devices market has been segmented as follows:

By Product type

  • Dry Powder Inhalers
    • Single-dose inhalers
    • Multi-dose inhalers
  • Metered Dose Inhalers
    • Manually-actuated pressurized inhaler
    • Breath-actuated pressurized inhaler
  • Nebulizers
    • Jet nebulizers
    • Ultrasonic wave nebulizers
    • Vibrating mesh nebulizers

By Application

  • Asthma
  • COPD
  • Cystic Fibrosis
  • Others

By Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • E-commerce

By Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

1.Preface

  • 1.1.Report Scope
  • 1.2.Market Segmentation
  • 1.3.Research Highlights

2.Assumptions and Research Methodology

  • 2.1.Assumptions
  • 2.2.Research Methodology

3.Executive Summary

4.Market Overview

  • 4.1.Product Type Overview
  • 4.2.Key Industry Events
  • 4.3.Market Opportunity Map

5.Market Dynamics

  • 5.1.Drivers and Restraints Snapshot Analysis
  • 5.2.Drivers
  • 5.3.Restraints
  • 5.4.Opportunity Analysis
  • 5.5.Opportunities
  • 5.6.Trends
  • 5.7.Porter's Five Forces Analysis
  • 5.8.Value Chain Snapshot

6.Pulmonary Drugs Market Analysis, by Product Type

  • 6.1.Key Findings
  • 6.2.Introduction
  • 6.3.Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type
  • 6.4.Global Pulmonary Drug Delivery Devices Market Forecast, by Product Type
    • 6.4.1.Global Dry Powder Inhalers (DPIs) Market Revenue (US$ Mn) and Volume (million units), 2014-2024
    • 6.4.2.Global Metered Dose Inhalers (MDIs) Market Revenue (US$ Mn) and Volume (million units), 2014-2024
    • 6.4.3.Global Nebulizers Market Revenue (US$ Mn) and Volume (million units), 2014-2024
  • 6.5.Global Pulmonary Drugs Market Attractiveness Analysis, by Product Type
  • 6.6.Key Trends

7.Pulmonary Drug Delivery Devices Market Analysis, by Application

  • 7.1.Key Findings
  • 7.2.Introduction
  • 7.3.Global Pulmonary Drug Delivery Devices Market Value Share Analysis, By Application, 2016 and 2024
  • 7.4.Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and volume (million units) Forecast, By Application, 2014-2024
    • 7.4.1.Global Asthma Market Revenue (US$ Mn) and volume (million units), 2014-2024
    • 7.4.2.Global COPD Market Revenue (US$ Mn) and volume (million units), 2014-2024
    • 7.4.3.Global Cystic Fibrosis Market Revenue (US$ Mn) and volume (million units), 2014-2024
    • 7.4.4.Global Other Applications Market Revenue (US$ Mn) and volume (million units), 2014-2024
    • 7.4.5.Global Pulmonary Drug Delivery Devices Market Attractiveness By Application
  • 7.5.Key Trends

8.Pulmonary Drug Delivery Devices Market Analysis, by Distribution Channel

  • 8.1.Key Findings
  • 8.2.Introduction
  • 8.3.Global Pulmonary Drug Delivery Devices Market Value Share Analysis, By Distribution Channel, 2016 and 2024
  • 8.4.Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, By Distribution Channel, 2015-2024
    • 8.4.1.Global Retail Pharmacies Market Revenue (US$ Mn) and Volume (million units), 2014-2024
    • 8.4.2.Global Hospital Pharmacies Market Revenue (US$ Mn) and Volume (million units), 2014-2024
    • 8.4.3.Global E-commerce Market Revenue (US$ Mn) and Volume (million units), 2014-2024
  • 8.5.Global Pulmonary Drug Delivery Devices Market Attractiveness by Distribution Channel

9.Pulmonary Drug Delivery Devices Market Analysis, By Region

  • 9.1.Global Scenario
  • 9.2.Global Pulmonary Drug Delivery Devices Market Value Share Analysis By Region, 2016 and 2024
  • 9.3.Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, By Region, 2016-2024
  • 9.4.Global Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Region

10.North America Pulmonary Drug Delivery Devices Market Analysis

  • 10.1.Key Findings
  • 10.2.North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, 2016-2024
  • 10.3. North America Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2015-2024
  • 10.4.North America Market Attractiveness Analysis, by Country
  • 10.5.North America Market Value Share Analysis, by Product Type, 2016 and 2024
  • 10.6.North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Product Type, 2016-2024
  • 10.7.North America Market Value Share Analysis, by Application, 2016 and 2024
  • 10.8.North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Application, 2016-2024
  • 10.9.North America Market Revenue Share Analysis, by Distribution Channel, 2016 and 2024
  • 10.10.North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Distribution Channel, 2016-2024
  • 10.11.North America Market Value Share Analysis, by Country, 2016 and 2024
  • 10.12.North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Country, 2016-2024
  • 10.13.North America Market Attractiveness Analysis, by Product Type
  • 10.14.North America Market Attractiveness Analysis, by Application
  • 10.15.North America Market Attractiveness Analysis, by Distribution Channel

11.Europe Pulmonary Drug Delivery Devices Market Analysis

  • 11.1.Key Findings
  • 11.2.Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, 2016-2024
  • 11.3. Europe Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2015-2024
  • 11.4.Europe Market Attractiveness Analysis, by Country
  • 11.5.Europe Market Value Share Analysis, by Product Type, 2016 and 2024
  • 11.6.Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Product Type, 2016-2024
  • 11.7.Europe Market Value Share Analysis, by Application, 2016 and 2024
  • 11.8.Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Application, 2016-2024
  • 11.9.Europe Market Revenue Share Analysis, by Distribution Channel, 2016 and 2024
  • 11.10.Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Distribution Channel, 2016-2024
  • 11.11.Europe Market Value Share Analysis, by Country, 2016 and 2024
  • 11.12.Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Country, 2016-2024
  • 11.13.Europe Market Attractiveness Analysis, by Product Type
  • 11.14.Europe Market Attractiveness Analysis, by Application
  • 11.15.Europe Market Attractiveness Analysis, by Distribution Channel

12.Asia Pacific Pulmonary Drug Delivery Devices Market Analysis

  • 12.1.Key Findings
  • 12.2.Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, 2016-2024
  • 12.3. Asia Pacific Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2015-2024
  • 12.4.Asia Pacific Market Attractiveness Analysis, by Country
  • 12.5.Asia Pacific Market Value Share Analysis, by Product Type, 2016 and 2024
  • 12.6.Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Product Type, 2016-2024
  • 12.7.Asia Pacific Market Value Share Analysis, by Application, 2016 and 2024
  • 12.8.Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Application, 2016-2024
  • 12.9.Asia Pacific Market Revenue Share Analysis, by Distribution Channel, 2016 and 2024
  • 12.10.Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Distribution Channel, 2016-2024
  • 12.11.Asia Pacific Market Value Share Analysis, by Country, 2016 and 2024
  • 12.12.Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Country, 2016-2024
  • 12.13.Asia Pacific Market Attractiveness Analysis, by Product Type
  • 12.14.Asia Pacific Market Attractiveness Analysis, by Application
  • 12.15.Asia Pacific Market Attractiveness Analysis, by Distribution Channel

13.Latin America Pulmonary Drug Delivery Devices Market Analysis

  • 13.1.Key Findings
  • 13.2.Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, 2016-2024
  • 13.3. Latin America Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2015-2024
  • 13.4.Latin America Market Attractiveness Analysis, by Country
  • 13.5.Latin America Market Value Share Analysis, by Product Type, 2016 and 2024
  • 13.6.Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Product Type, 2016-2024
  • 13.7.Latin America Market Value Share Analysis, by Application, 2016 and 2024
  • 13.8.Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Application, 2016-2024
  • 13.9.Latin America Market Revenue Share Analysis, by Distribution Channel, 2016 and 2024
  • 13.10.Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Distribution Channel, 2016-2024
  • 13.11.Latin America Market Value Share Analysis, by Country, 2016 and 2024
  • 13.12.Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Country, 2016-2024
  • 13.13.Latin America Market Attractiveness Analysis, by Product Type
  • 13.14.Latin America Market Attractiveness Analysis, by Application
  • 13.15.Latin America Market Attractiveness Analysis, by Distribution Channel

14.Middle East & Africa Pulmonary Drug Delivery Devices Market Analysis

  • 14.1.Key Findings
  • 14.2.Middle East & Africa Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, 2016-2024
  • 14.3. Middle East & Africa Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2015-2024
  • 14.4.Middle East & Africa Market Attractiveness Analysis, by Country
  • 14.5.Middle East & Africa Market Value Share Analysis, by Product Type, 2016 and 2024
  • 14.6.Middle East & Africa Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Product Type, 2016-2024
  • 14.7.Middle East & Africa Market Value Share Analysis, by Application, 2016 and 2024
  • 14.8.Middle East & Africa Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Application, 2016-2024
  • 14.9.Middle East & Africa Market Revenue Share Analysis, by Distribution Channel, 2016 and 2024
  • 14.10.Middle East & Africa Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Distribution Channel, 2016-2024
  • 14.11.Middle East & Africa Market Value Share Analysis, by Country, 2016 and 2024
  • 14.12.Middle East & Africa Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Country, 2016-2024
  • 14.13.Middle East & Africa Market Attractiveness Analysis, by Product Type
  • 14.14.Middle East & Africa Market Attractiveness Analysis, by Application
  • 14.15.Middle East & Africa Market Attractiveness Analysis, by Distribution Channel

15.Competition Landscape

  • 15.1.Global Pulmonary Drugs Market Share Analysis, By Company, (2015)
  • 15.2.Competitive Dashboard
  • 15.3.Pipeline Snapshot

16.Company Profiles

  • 16.1.Boehringer Ingelheim GmbH
    • 16.1.1.Company Overview
    • 16.1.2.Business Overview
    • 16.1.3.Financial Overview
    • 16.1.4.SWOT Analysis
    • 16.1.5.Strategic Overview
  • 16.2.Novartis AG
    • 16.2.1.Company Overview
    • 16.2.2.Business Overview
    • 16.2.3.Financial Overview
    • 16.2.4.SWOT Analysis
    • 16.2.5.Strategic Overview
  • 16.3.GlaxoSmithKline plc
    • 16.3.1.Company Overview
    • 16.3.2.Business Overview
    • 16.3.3.Financial Overview
    • 16.3.4.SWOT Analysis
    • 16.3.5.Strategic Overview
  • 16.4.AstraZeneca plc
    • 16.4.1.Company Overview
    • 16.4.2.Business Overview
    • 16.4.3.Financial Overview
    • 16.4.4.SWOT Analysis
    • 16.4.5.Strategic Overview
  • 16.5.Teva Pharmaceutical Industries Ltd.
    • 16.5.1.Company Overview
    • 16.5.2.Business Overview
    • 16.5.3.Financial Overview
    • 16.5.4.SWOT Analysis
    • 16.5.5.Strategic Overview
  • 16.6.Merck & Co., Inc.
    • 16.6.1.Company Overview
    • 16.6.2.Business Overview
    • 16.6.3.Financial Overview
    • 16.6.4.SWOT Analysis
    • 16.6.5.Strategic Overview
  • 16.7.MannKind Corporation
    • 16.7.1.Company Overview
    • 16.7.2.Business Overview
    • 16.7.3.Financial Overview
    • 16.7.4.SWOT Analysis
    • 16.7.5.Strategic Overview
  • 16.8.F. Hoffmann-La Roche Ltd.
    • 16.8.1.Company Overview
    • 16.8.2.Business Overview
    • 16.8.3.Financial Overview
    • 16.8.4.SWOT Analysis
    • 16.8.5.Strategic Overview
  • 16.9.Bristol-Myers Squibb Company
    • 16.9.1.Company Overview
    • 16.9.2.Business Overview
    • 16.9.3.Financial Overview
    • 16.9.4.SWOT Analysis
    • 16.9.5.Strategic Overview
  • 16.10.Mylan N.V.
    • 16.10.1. Company Overview
    • 16.10.2. Business Overview
    • 16.10.3. Financial Overview
    • 16.10.4. SWOT Analysis
    • 16.10.5. Strategic Overview
  • 16.11.Omron Corporation
    • 16.11.1.Company Overview
    • 16.11.2.Business Overview
    • 16.11.3.Financial Overview
    • 16.11.4.SWOT Analysis
    • 16.11.5.Strategic Overview
  • 16.12.3M Healthcare
    • 16.12.1.Company Overview
    • 16.12.2.Business Overview
    • 16.12.3.Financial Overview
    • 16.12.4.SWOT Analysis
    • 16.12.5.Strategic Overview
  • 16.13.Sunovion Pharmaceuticals, Inc.
    • 16.13.1.Company Overview
    • 16.13.2.Business Overview
    • 16.13.3.Financial Overview
    • 16.13.4.SWOT Analysis
    • 16.13.5.Strategic Overview
  • 16.14.Koninklijke Philips N.V.
    • 16.14.1.Company Overview
    • 16.14.2.Business Overview
    • 16.14.3.Financial Overview
    • 16.14.4.SWOT Analysis
    • 16.14.5.Strategic Overview
  • 16.15.Gerresheimer AG
    • 16.15.1.Company Overview
    • 16.15.2.Business Overview
    • 16.15.3.Financial Overview
    • 16.15.4.SWOT Analysis
    • 16.15.5.Strategic Overview
  • 16.16.Bespak
    • 16.16.1.Company Overview
    • 16.16.2.Business Overview
    • 16.16.3.Financial Overview
    • 16.16.4.SWOT Analysis
    • 16.16.5.Strategic Overview
  • 16.17.AptarGroup, Inc.
    • 16.17.1.Company Overview
    • 16.17.2.Business Overview
    • 16.17.3.Financial Overview
    • 16.17.4.SWOT Analysis
    • 16.17.5.Strategic Overview
  • 16.18.SHL Group
    • 16.18.1. Company Overview
    • 16.18.2. Business Overview
    • 16.18.3. SWOT Analysis
    • 16.18.4. Strategic Overview
  • 16.19.Nypro Healthcare Inc. (Jabil Circuit Inc.)
    • 16.19.1.Company Overview
    • 16.19.2.Business Overview
    • 16.19.3.Financial Overview
    • 16.19.4.SWOT Analysis
    • 16.19.5.Strategic Overview
  • 16.20.Hovione
    • 16.20.1.Company Overview
    • 16.20.2.Business Overview
    • 16.20.3.Financial Overview
    • 16.20.4.SWOT Analysis
    • 16.20.5.Strategic Overview
  • 16.21.Chiesi Farmaceutici S.p.A.
    • 16.21.1.Company Overview
    • 16.21.2.Business Overview
    • 16.21.3.Financial Overview
    • 16.21.4.SWOT Analysis
    • 16.21.5.Strategic Overview

List of Figures

  • Figure 01: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type, 2016 and 2024
  • Figure 02: Global Dry Powder Inhalers Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014-2024
  • Figure 03: Global Dry Powder Inhalers Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015-2024
  • Figure 04: Global Metered Dose Inhalers Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2015-2024
  • Figure 05: Global Metered Dose Inhalers Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015-2024
  • Figure 06: Global Nebulizers Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2015-2024
  • Figure 07: Global Nebulizers Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015-2024
  • Figure 08: Global Single Dose Inhaler Market Volume and Y-o-Y Growth (%), 2015-2024
  • Figure 09: Global Multi Dose Inhaler Market Volume and Y-o-Y Growth (%), 2014-2024
  • Figure 10: Global Manually-actuated pressurized inhaler Market Volume and Y-o-Y Growth (%), 2015-2024
  • Figure 11: Global Breath-actuated pressurized inhaler Market Volume and Y-o-Y Growth (%), 2014-2024
  • Figure 12: Global Jet Nebulizers Market Volume and Y-o-Y Growth (%), 2015-2024
  • Figure 13: Global Ultrasonic Wave Nebulizers Market Volume and Y-o-Y Growth (%), 2014-2024
  • Figure 14: Global Vibrating Mesh Nebulizers Market Volume and Y-o-Y Growth (%), 2014-2024
  • Figure 15: Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product Type
  • Figure 16: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2016 and 2024
  • Figure 17: Global Asthma Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014-2024
  • Figure 18: Asthma Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015-2024
  • Figure 19: Global COPD Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014-2024
  • Figure 20: COPD Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015-2024
  • Figure 21: Global Cystic Fibrosis Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014-2024
  • Figure 22: Cystic Fibrosis Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015-2024
  • Figure 23: Global Others Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014-2024
  • Figure 24: Others Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015-2024
  • Figure 25: Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application
  • Figure 26: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2016 and 2024
  • Figure 27: Global Retail Pharmacies Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014-2024
  • Figure 28: Retail Pharmacies Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015-2024
  • Figure 29: Global Hospital Pharmacies Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014-2024
  • Figure 31: Global E-commerce Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014-2024
  • Figure 32: E-commerce Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015-2024
  • Figure 33: Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel
  • Figure 34: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Region, 2016 and 2024
  • Figure 35: Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Region
  • Figure 36: North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, 2016-2024
  • Figure 37: North America Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2015-2024
  • Figure 38: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Country
  • Figure 39: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product, 2016 and 2024
  • Figure 40: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2016 and 2024
  • Figure 41: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2016 and 2024
  • Figure 42: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country, 2016 and 2024
  • Figure 43: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product
  • Figure 44: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application
  • Figure 45: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel
  • Figure 46: Europe Pulmonary drug delivery devices Market Size (US$ Mn) and Volume (Million Units) Forecast, 2016-2024
  • Figure 47: Europe Pulmonary drug delivery devices Market Size and Volume Y-o-Y Growth Projections, 2015-2024
  • Figure 48: Europe Pulmonary drug delivery devices Market Attractiveness Analysis, by Country
  • Figure 49: Europe Market Value Share Analysis, by Product Type, 2016 and 2024
  • Figure 50: Europe Market Value Share Analysis, by Application, 2016 and 2024
  • Figure 51: Europe Market Value Share Analysis, by Distribution Channel, 2016 and 2024
  • Figure 52: Europe Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country, 2016 and 2024
  • Figure 53: Europe Market Attractiveness Analysis, by Product Type
  • Figure 54: Europe Market Attractiveness Analysis, by Application
  • Figure 55: Europe Market Attractiveness Analysis, by Distribution Channel
  • Figure 56: Asia Pacific Pulmonary drug delivery devices Market Size (US$ Mn) and Volume (Million Units) Forecast, 2016-2024
  • Figure 57: Asia Pacific Pulmonary drug delivery devices Market Y-o-Y Analysis, by Country
  • Figure 58: Asia Pacific Market Attractiveness Analysis, by Country
  • Figure 59: Asia Pacific Market Value Share Analysis, by Product Type, 2016 and 2024
  • Figure 60: Asia Pacific Market Value Share Analysis, by Application, 2016 and 2024
  • Figure 61: Asia Pacific Market Value Share Analysis, by Distribution Channel, 2016 and 2024
  • Figure 62: Asia Pacific Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country, 2016 and 2024
  • Figure 63: Asia Pacific Market Attractiveness Analysis, by Product Type
  • Figure 64: Asia Pacific Market Attractiveness Analysis, by Application
  • Figure 65: Asia Pacific Market Attractiveness Analysis, by Distribution Channel
  • Figure 66: Latin Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million units) Forecast, 2016-2024
  • Figure 67: Latin America Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2015-2024
  • Figure 68: Latin America Market Attractiveness Analysis, by Country
  • Figure 69: Latin America Market Value Share Analysis, by Product Type, 2016 and 2024
  • Figure 70: Latin America Market Value Share Analysis, by Application, 2016 and 2024
  • Figure 71: Latin America Market Value Share Analysis, by Distribution Channel, 2016 and 2024
  • Figure 72: Latin America Market Value Share Analysis, by Country, 2016 and 2024
  • Figure 73: Latin America Market Attractiveness Analysis, by Product Type
  • Figure 74: Latin America Market Attractiveness Analysis, by Application
  • Figure 75: Latin America Market Attractiveness Analysis, by Distribution Channel
  • Figure 76: MEA Market Size Value (US$ Mn) and Volume (Million Units) Forecast, 2016-2024
  • Figure 77: MEA Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2015-2024
  • Figure 78: Middle East & Africa Market Attractiveness Analysis, by Country
  • Figure 79: Middle East & Africa Market Value Share Analysis, by Product Type, 2016 and 2024
  • Figure 80: Middle East & Africa Market Value Share Analysis, by Application, 2016 and 2024
  • Figure 81: Middle East & Africa Market Value Share Analysis, by Distribution Channel, 2016 and 2024
  • Figure 82: Middle East & Africa Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country, 2016 and 2024
  • Figure 83: Middle East & Africa Market Attractiveness Analysis, by Product Type
  • Figure 84: Middle East & Africa Market Attractiveness Analysis, by Application
  • Figure 85: Middle East & Africa Market Attractiveness Analysis, by Distribution Channel
  • Figure 86: Global Pulmonary Drug Delivery Devices Market Share Analysis, by Company (2015)

List of Tables

  • Table 01: Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Product Type, 2016-2024
  • Table 02: Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Dry Powder Inhaler), 2016-2024
  • Table 03: Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Metered Dose Inhaler), 2016-2024
  • Table 04: Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Nebulizer), 2016-2024
  • Table 05: Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2016-2024
  • Table 06: Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2014-2024
  • Table 07: Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Region, 2016-2024
  • Table 08: North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2016-2024
  • Table 09: North America Pulmonary Drug Delivery Devices Volume (Million Units) Forecast, by Dry Powder Inhalers (Product) 2016-2024
  • Table 10: North America Pulmonary Drug Delivery Devices Volume (Million Units) Forecast, by Metered Dose Inhalers (Product) 2016-2024
  • Table 11: North America Pulmonary Drug Delivery Devices Volume (Million Units) Forecast, by Nebulizers (Product) 2016-2024
  • Table 12: North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2016-2024
  • Table 13: North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel 2016-2024
  • Table 14: North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Country, 2016-2024
  • Table 15: Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2016-2024
  • Table 16: Europe Pulmonary Drug Delivery Devices Volume (Million Units) Forecast, by Product Type, (Dry Powder Inhaler) 2016-2024
  • Table 17: Europe Pulmonary Drug Delivery Devices Volume (Million Units) Forecast, by Product Type, (Metered Dose Inhaler) 2016-2024
  • Table 18: Europe Pulmonary Drug Delivery Devices and Volume (Million Units) Forecast, by Product Type, (Nebulizer) 2016-2024
  • Table 19: Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2016-2024
  • Table 20: Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2016-2024
  • Table 21: Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) ) and Volume (Million Units) Forecast, by Country, 2016-2024
  • Table 22: Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2016-2024
  • Table 23: Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Dry Powder Inhaler) 2016-2024
  • Table 24: Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Metered Dose Inhaler) 2016-2024
  • Table 25: Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Nebulizer) 2016-2024
  • Table 26: Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2016-2024
  • Table 27: Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2016-2024
  • Table 28: Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) ) and Volume (Million Units) Forecast, by Country, 2016-2024
  • Table 29: Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2016-2024
  • Table 30: Latin America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Dry Powder Inhaler) 2016-2024
  • Table 31: Latin America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Metered Dose Inhaler) 2016-2024
  • Table 32: Latin America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Nebulizer) 2016-2024
  • Table 33: Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2016-2024
  • Table 34: Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2016-2024
  • Table 35: Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Country, 2016-2024
  • Table 36: Middle East & Africa Pulmonary Drug Delivery Devices Market Size Value (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2016-2024
  • Table 37: Middle East & Africa Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Dry Powder Inhaler) 2016-2024
  • Table 38: Middle East & Africa Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Metered Dose Inhaler) 2016-2024
  • Table 39: Middle East & Africa Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Nebulizer) 2016-2024
  • Table 40: Middle East & Africa Pulmonary Drug Delivery Devices Market Size Value (US$ Mn) and Volume (Million Units) Forecast, by Application, 2016-2024
  • Table 41: Middle East & Africa Pulmonary Drug Delivery Devices Market Size Value (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2016-2024
  • Table 42: Middle East & Africa Pulmonary Drug Delivery Devices Market Size (US$ Mn) ) and Volume (Million Units) Forecast, by Country, 2016-2024
Back to Top